DJIA 17,083.80 -2.83 -0.02%
NASDAQ 4,472.11 -1.59 -0.04%
S&P 500 1,987.98 0.97 0.05%
market minute promo

Santarus, Inc. (NASDAQ: SNTS)

0.00 0.00 (0.00%)

Quote as of


company name or ticker

Recent Quotes

SNTS $0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $0.00 - $0.00
Market Cap $0.00
P/E Ratio 0.00
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS $1.10

Sector

Healthcare

Industry

Drugs

Santarus, Inc. (SNTS) Description

A pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists or primary care physicians. Website: http://www.santarus.com/

News & Commentary

Tracking John Paulson's Paulson & Company Portfolio - Q1 2014 Update

Mario Gabelli Comments on Santarus Inc.

Mario Gabelli Comments on Valassis Communications

Mario Gabelli's Top 5 Fourth-Quarter Stock Buys

RedHill Biopharma Sells ADS - Analyst Blog

Durata Progresses with Dalbavancin - Analyst Blog

Pipeline Update on Aratana - Analyst Blog

Update on MDCO's Pipeline - Analyst Blog

Why You Need To Watch Johnson & Johnson, The Medicines Company, Santarus, and Tesaro Today

Johnson & Johnson, The Medicines Company, Santarus, and Tesaro could loom large in health care headlines this morning. Here’s why.

Novartis' Sandoz receives AirFluSal Forspiro approval - Analyst Blog

Novartis' Sandoz receives AirFluSal Forspiro approval - Analyst Blog

See More SNTS News...

SNTS's Top Competitors

SNTS $0.00 (0.00%)
Current stock: SNTS
PFE $30.34 (-0.16%)
Current stock: PFE
JNJ $102.20 (0.01%)
Current stock: JNJ
RHHBY $37.24 (1.14%)
Current stock: RHHBY